vs

Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $162.5M, roughly 1.4× Bitcoin Depot Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 3.4%, a 16.0% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 20.1%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $2.5M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -4.9%).

Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

BTM vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.4× larger
ORGO
$225.6M
$162.5M
BTM
Growing faster (revenue YoY)
ORGO
ORGO
+58.0% gap
ORGO
78.1%
20.1%
BTM
Higher net margin
ORGO
ORGO
16.0% more per $
ORGO
19.4%
3.4%
BTM
More free cash flow
ORGO
ORGO
$32.2M more FCF
ORGO
$34.8M
$2.5M
BTM
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-4.9%
BTM

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BTM
BTM
ORGO
ORGO
Revenue
$162.5M
$225.6M
Net Profit
$5.5M
$43.7M
Gross Margin
Operating Margin
7.3%
28.1%
Net Margin
3.4%
19.4%
Revenue YoY
20.1%
78.1%
Net Profit YoY
690.4%
469.5%
EPS (diluted)
$0.08
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTM
BTM
ORGO
ORGO
Q4 25
$225.6M
Q3 25
$162.5M
$150.9M
Q2 25
$172.1M
$101.0M
Q1 25
$164.2M
$86.7M
Q4 24
$126.7M
Q3 24
$135.3M
$115.2M
Q2 24
$163.1M
$130.2M
Q1 24
$138.5M
$110.0M
Net Profit
BTM
BTM
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$5.5M
$21.6M
Q2 25
$6.1M
$-9.4M
Q1 25
$4.2M
$-18.8M
Q4 24
$7.7M
Q3 24
$-939.0K
$12.3M
Q2 24
$-2.6M
$-17.0M
Q1 24
$-1.5M
$-2.1M
Gross Margin
BTM
BTM
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
BTM
BTM
ORGO
ORGO
Q4 25
28.1%
Q3 25
7.3%
13.7%
Q2 25
9.2%
-12.5%
Q1 25
10.8%
-30.9%
Q4 24
8.1%
Q3 24
4.1%
5.4%
Q2 24
4.7%
-10.7%
Q1 24
0.5%
-3.5%
Net Margin
BTM
BTM
ORGO
ORGO
Q4 25
19.4%
Q3 25
3.4%
14.3%
Q2 25
3.5%
-9.3%
Q1 25
2.6%
-21.7%
Q4 24
6.1%
Q3 24
-0.7%
10.7%
Q2 24
-1.6%
-13.1%
Q1 24
-1.1%
-1.9%
EPS (diluted)
BTM
BTM
ORGO
ORGO
Q4 25
$0.31
Q3 25
$0.08
$0.11
Q2 25
$0.16
$-0.10
Q1 25
$0.20
$-0.17
Q4 24
$0.05
Q3 24
$-0.05
$0.09
Q2 24
$-0.13
$-0.13
Q1 24
$-0.25
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTM
BTM
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$59.3M
$93.7M
Total DebtLower is stronger
$67.5M
Stockholders' EquityBook value
$21.0M
$300.1M
Total Assets
$125.3M
$598.7M
Debt / EquityLower = less leverage
3.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTM
BTM
ORGO
ORGO
Q4 25
$93.7M
Q3 25
$59.3M
$63.7M
Q2 25
$48.0M
$73.1M
Q1 25
$35.0M
$110.0M
Q4 24
$135.6M
Q3 24
$32.2M
$94.3M
Q2 24
$43.9M
$89.9M
Q1 24
$42.2M
$88.6M
Total Debt
BTM
BTM
ORGO
ORGO
Q4 25
Q3 25
$67.5M
Q2 25
$66.5M
Q1 25
$56.2M
Q4 24
Q3 24
$44.5M
$62.3M
Q2 24
$41.2M
$63.8M
Q1 24
$37.6M
$65.2M
Stockholders' Equity
BTM
BTM
ORGO
ORGO
Q4 25
$300.1M
Q3 25
$21.0M
$255.1M
Q2 25
$4.7M
$233.2M
Q1 25
$-4.6M
$242.9M
Q4 24
$262.9M
Q3 24
$-7.9M
$278.5M
Q2 24
$4.4M
$263.5M
Q1 24
$5.0M
$278.0M
Total Assets
BTM
BTM
ORGO
ORGO
Q4 25
$598.7M
Q3 25
$125.3M
$509.8M
Q2 25
$109.1M
$461.1M
Q1 25
$89.7M
$467.4M
Q4 24
$497.9M
Q3 24
$87.4M
$446.3M
Q2 24
$97.5M
$443.2M
Q1 24
$90.1M
$458.5M
Debt / Equity
BTM
BTM
ORGO
ORGO
Q4 25
Q3 25
3.21×
Q2 25
14.18×
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
9.27×
0.24×
Q1 24
7.54×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTM
BTM
ORGO
ORGO
Operating Cash FlowLast quarter
$6.6M
$39.4M
Free Cash FlowOCF − Capex
$2.5M
$34.8M
FCF MarginFCF / Revenue
1.6%
15.4%
Capex IntensityCapex / Revenue
2.5%
2.1%
Cash ConversionOCF / Net Profit
1.20×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$27.1M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTM
BTM
ORGO
ORGO
Q4 25
$39.4M
Q3 25
$6.6M
$3.1M
Q2 25
$10.2M
$-32.9M
Q1 25
$16.3M
$-19.9M
Q4 24
$10.9M
Q3 24
$5.8M
$8.7M
Q2 24
$10.1M
$4.7M
Q1 24
$1.3M
$-10.2M
Free Cash Flow
BTM
BTM
ORGO
ORGO
Q4 25
$34.8M
Q3 25
$2.5M
$844.0K
Q2 25
$9.8M
$-36.5M
Q1 25
$15.9M
$-23.6M
Q4 24
$7.6M
Q3 24
$-1.0M
$6.1M
Q2 24
$7.6M
$2.9M
Q1 24
$789.0K
$-12.4M
FCF Margin
BTM
BTM
ORGO
ORGO
Q4 25
15.4%
Q3 25
1.6%
0.6%
Q2 25
5.7%
-36.1%
Q1 25
9.7%
-27.2%
Q4 24
6.0%
Q3 24
-0.8%
5.3%
Q2 24
4.7%
2.2%
Q1 24
0.6%
-11.3%
Capex Intensity
BTM
BTM
ORGO
ORGO
Q4 25
2.1%
Q3 25
2.5%
1.5%
Q2 25
0.2%
3.6%
Q1 25
0.2%
4.2%
Q4 24
2.7%
Q3 24
5.0%
2.2%
Q2 24
1.5%
1.4%
Q1 24
0.4%
2.0%
Cash Conversion
BTM
BTM
ORGO
ORGO
Q4 25
0.90×
Q3 25
1.20×
0.14×
Q2 25
1.67×
Q1 25
3.88×
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons